(Q50919131)

English

Tolerability profile of zolmitriptan (Zomig; 311C90), a novel dual central and peripherally acting 5HT1B/1D agonist. International clinical experience based on > 3000 subjects treated with zolmitriptan.

scientific article published in October 1997

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/9399016

Tolerability profile of zolmitriptan (Zomig; 311C90), a novel dual central and peripherally acting 5HT1B/1D agonist. International clinical experience based on > 3000 subjects treated with zolmitriptan. (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/9399016

author name string

J G Edmeads

1

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/9399016

D S Millson

2

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/9399016

language of work or name

0 references

publication date

1 October 1997

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/9399016

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/9399016

17 Suppl 18

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/9399016

41-52

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/9399016

Migraine symptoms: results of a survey of self-reported migraineurs

1 reference

https://api.crossref.org/works/10.1177%2F0333102497017S1806

21 January 2018

Inhibition of the trigemino-vascular system with 5-HT1D agonist drugs: selectively targeting additional sites of action

1 reference

https://api.crossref.org/works/10.1177%2F0333102497017S1806

21 January 2018

The clinical pharmacokinetics of zolmitriptan.

1 reference

https://api.crossref.org/works/10.1177%2F0333102497017S1806

21 January 2018

Pre-clinical pharmacology of zolmitriptan (Zomig; formerly 311C90), a centrally and peripherally acting 5HT1B/1D agonist for migraine

1 reference

https://api.crossref.org/works/10.1177%2F0333102497017S1806

21 January 2018

Inhibition of trigeminal neurons by intravenous administration of the serotonin (5HT)1B/D receptor agonist zolmitriptan (311C90): are brain stem sites therapeutic target in migraine?

1 reference

https://api.crossref.org/works/10.1177%2F0333102497017S1806

21 January 2018

311C90: patient profiles and typical case histories of migraine management

1 reference

https://api.crossref.org/works/10.1177%2F0333102497017S1806

21 January 2018

Rizatriptan vs sumatriptan in the acute treatment of migraine. A placebo-controlled, dose-ranging study. Dutch/US Rizatriptan Study Group

1 reference

https://api.crossref.org/works/10.1177%2F0333102497017S1806

21 January 2018

Chest symptoms after sumatriptan: a two-year clinical practice review in 735 consecutive migraine patients

1 reference

https://api.crossref.org/works/10.1177%2F0333102497017S1806

21 January 2018

Serotonin 1D (5-HT1D) agonists and other agents in acute migraine

1 reference

https://api.crossref.org/works/10.1177%2F0333102497017S1806

21 January 2018

The pharmacokinetics and effects on blood pressure of multiple doses of the novel anti-migraine drug zolmitriptan (311C90) in healthy volunteers

1 reference

https://api.crossref.org/works/10.1177%2F0333102497017S1806

21 January 2018

311C90: increasing the options for therapy with effective acute antimigraine 5HT1B/1D receptor agonists

1 reference

https://api.crossref.org/works/10.1177%2F0333102497017S1806

21 January 2018

Inhibition by sumatriptan of central trigeminal neurones only after blood-brain barrier disruption

1 reference

https://api.crossref.org/works/10.1177%2F0333102497017S1806

21 January 2018

Potential drug interactions with the novel antimigraine compound zolmitriptan (Zomig, 311C90)

1 reference

https://api.crossref.org/works/10.1177%2F0333102497017S1806

21 January 2018

Identifiers

10.1177/0333102497017S1806

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/9399016

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/9399016

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50919131&oldid=977512059"